Mitsugu Kochi
Department of Digestive Surgery
Nihon University School of Medicine
Itabashi-ku
Tokyo
Japan
Name/email consistency: low
- Irinotecan plus S-1 for liver metastases of gastric cancer. Kochi, M., Fujii, M., Kanamori, N., Kaiga, T., Okubo, R., Hagiwara, K., Funada, T., Tamegai, H., Takayama, T. Hepatogastroenterology (2009)
- Complete remission by chemotherapy in stage IE-IIE primary gastric lymphoma. Kochi, M., Fujii, M., Kanamori, N., Kaiga, T., Takahashi, T., Kobayashi, M., Takayama, T. Hepatogastroenterology (2007)
- Effect of gastrectomy on the pharmacokinetics of S-1, an oral fluoropyrimidine, in resectable gastric cancer patients. Kochi, M., Fujii, M., Kanamori, N., Kaiga, T., Aizaki, K., Takahashi, T., Takayama, T. Cancer Chemother. Pharmacol. (2007)
- Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer. Kochi, M., Fujii, M., Kanamori, N., Kaiga, T., Takahashi, T., Kobayashi, M., Takayama, T. J. Cancer Res. Clin. Oncol. (2006)
- FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer. Kochi, M., Fujii, M., Kaiga, T., Takahashi, T., Morishita, Y., Kobayashi, M., Kasakura, Y., Takayama, T. Oncology (2004)